Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene and Baclofen on Impulsivity in Alcohol Use Disorder
NCT03034408Phase 2Completed
- Start
- Jul 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nalmefene, baclofen in alcohol use disorder (AUD). Started Jul 2016; status: completed.
02
Drugs
nalmefenebaclofen
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03034408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03034408.